Thomas Woiwode Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas Woiwode.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas Woiwode. Thomas Woiwode is a Director in Adverum Biotechnologies, Inc. ($AAVL) and a Director in Audentes Therapeutics, Inc. ($BOLD) and a Director in CRISPR Therapeutics AG ($CRSP) and a Director in Gritstone Oncology, Inc. ($GRTS) and a Director in Passage BIO, Inc. ($PASG) and a Director in Aligos Therapeutics, Inc. ($ALGS).
Address: C/O ADVERUM BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE MENLO PARK 94025 CA
Companies in which Thomas Woiwode is an Insider
Adverum Biotechnologies, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Thomas Woiwode: Director
Holdings: 18,822 shares
Latest Transaction: May 14 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aligos Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Thomas Woiwode: Director
Holdings: 1,943,916 shares
Latest Transaction: Apr 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Audentes Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Thomas Woiwode: Director
Holdings: 1,081,477 shares
Current Value: $17,119,781
Latest Transaction: Aug 25 2016
$BOLD Market Capitalization: $337.82M
$BOLD Previous Close: $15.83
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CRISPR Therapeutics AG
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Thomas Woiwode: Director
Holdings: 641,014 shares
Current Value: $10,095,971
Latest Transaction: Jun 15 2018
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Gritstone bio, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Thomas Woiwode: Director
Holdings: 1,347,709 shares
Latest Transaction: Jan 04 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Passage BIO, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Thomas Woiwode: Director
Holdings: 0 shares
Latest Transaction: May 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Thomas Woiwode
Sentiment: All, ADVM, ALGS, BOLD, CRSP, GRTS, PASG
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2021 | PASG | Passage BIO, Inc. | Woiwode Thomas | Director | Option Exercise | A | 13.83 | 16,918 | 233,976 | 16,918 | |
| May 14 2021 | ADVM | Adverum Biotechnol ... | Woiwode Thomas | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| Apr 28 2021 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | J | 0.00 | 2,226 | 0 | 2,226 | 0 to 2.2 K |
| Apr 28 2021 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Sell | J | 0.00 | 8,385 | 0 | 0 | 8.4 K to 0 (-100.00 %) |
| Apr 28 2021 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | J | 0.00 | 8,385 | 0 | 8,385 | 0 to 8.4 K |
| Apr 28 2021 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Sell | J | 0.00 | 9,720 | 0 | 0 | 9.7 K to 0 (-100.00 %) |
| Apr 28 2021 | ALGS | Aligos Therapeutic ... | Woiwode Thomas | Director | Buy | J | 0.00 | 9,720 | 0 | 9,720 | 0 to 9.7 K |